GRDN logo

GRDN Guardian Pharmacy Services Inc

$41.88
$1.04
(2.55%)
Today
39

Bearish Sentiment

How do you feel about GRDN?

Loading...
Zacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBF
DuPont analysis highlights CNXN, ECG, GRDN, EXPD and PBF, with strong earnings surprises supporting the screen's stock picks.
Zacks
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap CNXN, ECG, GRDN, EXPD and PBF.
Zacks
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nations largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of assets from Tennessee-based Nautilus Pharmacy, including prescription files, related pharmacy inventory, and certain...
Business Wire
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 2:25 p.m. Central Standard Time that same...
Business Wire
Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates
Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +11.54% and +3.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue...
Business Wire
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference...
Business Wire
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?
Xeris Biopharma (XERS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nations largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Wellness Concepts, an LTC pharmacy based in Grottoes, Va. This addition expands Guardians footprint in Virginia to three...
Business Wire